{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:18:06Z","timestamp":1791645486849,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00520-023-07677-8","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:02:48Z","timestamp":1679022168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Topical non-steroidal agents for the prevention of radiation dermatitis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"31","author":[{"given":"Sakeena","family":"Fatima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Nader","family":"Marta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Caini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Beveridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ryan Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Behroozian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"7677_CR1","doi-asserted-by":"publisher","first-page":"738851","DOI":"10.3389\/fonc.2021.738851","volume":"11","author":"Y Xie","year":"2021","unstructured":"Xie Y et al (2021) Risk factors related to acute radiation dermatitis in breast cancer patients after radiotherapy: a systematic review and meta-analysis. Front Oncol 11:738851. https:\/\/doi.org\/10.3389\/fonc.2021.738851","journal-title":"Front Oncol"},{"issue":"2","key":"7677_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jaad.2019.02.047","volume":"81","author":"A Rosenthal","year":"2019","unstructured":"Rosenthal A, Israilevich R, Moy R (2019) Management of acute radiation dermatitis: a review of the literature and proposal for treatment algorithm. J Am Acad Dermatol 81(2):558\u2013567. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.047","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"7677_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00520-016-3521-7","volume":"25","author":"EB Ferreira","year":"2017","unstructured":"Ferreira EB et al (2017) Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review. Support Care Cancer 25(3):1001\u20131011. https:\/\/doi.org\/10.1007\/s00520-016-3521-7","journal-title":"Support Care Cancer"},{"issue":"3","key":"7677_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.breast.2015.01.008","volume":"24","author":"CJ Huang","year":"2015","unstructured":"Huang CJ et al (2015) RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements. Breast 24(3):230\u2013236. https:\/\/doi.org\/10.1016\/j.breast.2015.01.008","journal-title":"Breast"},{"issue":"1","key":"7677_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaad.2019.03.011","volume":"86","author":"A Rzepecki","year":"2022","unstructured":"Rzepecki A et al (2022) Characterizing the effects of radiation dermatitis on quality of life: a prospective survey-based study. J Am Acad Dermatol 86(1):161\u2013163. https:\/\/doi.org\/10.1016\/j.jaad.2019.03.011","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"7677_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/ijd.13371","volume":"56","author":"F Hegedus","year":"2017","unstructured":"Hegedus F, Mathew LM, Schwartz RA (2017) Radiation dermatitis: an overview. Int J Dermatol 56(9):909\u2013914. https:\/\/doi.org\/10.1111\/ijd.13371","journal-title":"Int J Dermatol"},{"key":"7677_CR7","volume-title":"Dermatology","author":"J Bolognia","year":"2012","unstructured":"Bolognia J, Jorizzo JL, Schaffer JV (2012) Dermatology, 3rd edn. Elsevier Saunders, Philadelphia","edition":"3"},{"issue":"10","key":"7677_CR8","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s00520-013-1896-2","volume":"21","author":"RK Wong","year":"2013","unstructured":"Wong RK et al (2013) Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer 21(10):2933\u20132948. https:\/\/doi.org\/10.1007\/s00520-013-1896-2","journal-title":"Support Care Cancer"},{"issue":"3","key":"7677_CR9","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1136\/bmj.n71","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18(3):e1003583. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"PLoS Med"},{"issue":"7650","key":"7677_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347","journal-title":"BMJ"},{"issue":"7","key":"7677_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0895-4356(96)00019-4","volume":"49","author":"DC Hadorn","year":"1996","unstructured":"Hadorn DC et al (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49(7):749\u2013754. https:\/\/doi.org\/10.1016\/0895-4356(96)00019-4","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"7677_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00520-011-1110-3","volume":"20","author":"H Abbas","year":"2012","unstructured":"Abbas H, Bensadoun RJ (2012) Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck. Support Care Cancer 20(1):185\u2013190. https:\/\/doi.org\/10.1007\/s00520-011-1110-3","journal-title":"Support Care Cancer"},{"issue":"13","key":"7677_CR13","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1200\/JCO.2005.04.9148","volume":"24","author":"EA Elliott","year":"2006","unstructured":"Elliott EA et al (2006) Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99\u201313. J Clin Oncol 24(13):2092\u20132097. https:\/\/doi.org\/10.1200\/JCO.2005.04.9148","journal-title":"J Clin Oncol"},{"issue":"5","key":"7677_CR14","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/s0360-3016(00)00782-3","volume":"48","author":"J Fisher","year":"2000","unstructured":"Fisher J et al (2000) Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97\u201313. Int J Radiat Oncol Biol Phys 48(5):1307\u20131310. https:\/\/doi.org\/10.1016\/s0360-3016(00)00782-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"7677_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1211\/jpp.62.06.0015","volume":"62","author":"L Rizza","year":"2010","unstructured":"Rizza L et al (2010) Evaluation of the effect of topical agents on radiation-induced skin disease by reflectance spectrophotometry. J Pharm Pharmacol 62(6):779\u2013785. https:\/\/doi.org\/10.1211\/jpp.62.06.0015","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"7677_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ijrobp.2011.09.021","volume":"83","author":"C Pinnix","year":"2012","unstructured":"Pinnix C et al (2012) Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys 83(4):1089\u201394. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.09.021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"7677_CR17","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00520-019-04957-0","volume":"28","author":"A Rahimi","year":"2020","unstructured":"Rahimi A et al (2020) Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial. Support Care Cancer 28(3):1481\u20131489. https:\/\/doi.org\/10.1007\/s00520-019-04957-0","journal-title":"Support Care Cancer"},{"issue":"6","key":"7677_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1188\/20.ONF.654-670","volume":"47","author":"T Gosselin","year":"2020","unstructured":"Gosselin T et al (2020) ONS Guidelines\u2122 for cancer treatment-related radiodermatitis. Oncol Nurs Forum 47(6):654\u2013670. https:\/\/doi.org\/10.1188\/20.ONF.654-670","journal-title":"Oncol Nurs Forum"},{"key":"7677_CR19","unstructured":"Hughes A, Mitchell A, Bianchini J et al (2018) Symptom management\nguidelines: radiation dermatitis. https:\/\/www.bccancer.bc.ca\/nursing-site\/Documents\/16.%20Radiation%20Dermatitis.pdf"},{"key":"7677_CR20","unstructured":"The Society and College of Radiographers (2020) Radiation dermatitis\nguidelines for radiotherapy healthcare professionals. https:\/\/www.sor.org\/learning-advice\/professional-body-guidance-and-publications\/documents-and-publications\/policy-guidance- document-library\/radiation-dermatitis-guidelines-for-radiotherapy-h"},{"key":"7677_CR21","unstructured":"Johnston P (2018) Evidence based recommendations for the assessment and management of radiation-induced skin toxicities in breast cancer. Part 5. Management of long-term effects [Internet]. CancerCare Manitoba. Available from: https:\/\/www.cancercare.mb.ca\/export\/sites\/default\/For-Health-Professionals\/.galleries\/files\/treatment-guidelines-rro-files\/practice-guidelines\/supportive-care\/Part_5_Management_of_Long-Term_Effects.pdf"},{"key":"7677_CR22","unstructured":"Johnston P (2018) Evidence based recommendations for the assessment and management of radiation-induced skin toxicities in breast cancer. Part 4. Management of acute radiation-induced skin toxicities [Internet]. CancerCare Manitoba. Available from: https:\/\/www.cancercare.mb.ca\/export\/sites\/default\/For-Health-Professionals\/.galleries\/files\/treatment-guidelines-rro-files\/practice-guidelines\/supportive-care\/Part_4_Management_of_Acute_Radiation-Induced_Skin_Toxicities.pdf"},{"key":"7677_CR23","unstructured":"Agbejule A, Hargrave C, Chia D et al (2021) Evidenced-based guidelines\nfor the prevention and management of radiation dermatitis\u2014\nInternational Society of Nurses in Cancer Care. https:\/\/www. isncc.org\/resources\/Documents\/Resources\/Practice%20 Guidelines\/Report_RDguidelines_CFVersion_2021_FINALs.pdf"},{"issue":"6","key":"7677_CR24","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1007\/s00520-022-06829-6","volume":"30","author":"S Finkelstein","year":"2022","unstructured":"Finkelstein S et al (2022) Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Support Care Cancer 30(6):4663\u20134674. https:\/\/doi.org\/10.1007\/s00520-022-06829-6","journal-title":"Support Care Cancer"},{"issue":"5","key":"7677_CR25","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1007\/s00520-022-06828-7","volume":"30","author":"CJ Lee","year":"2022","unstructured":"Lee CJ et al (2022) Effect of hyaluronic acid on radiodermatitis in patients with breast cancer: a meta-analysis of randomized controlled trials. Support Care Cancer 30(5):3965\u20133975. https:\/\/doi.org\/10.1007\/s00520-022-06828-7","journal-title":"Support Care Cancer"},{"issue":"15","key":"7677_CR26","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","volume":"35","author":"C Taylor","year":"2017","unstructured":"Taylor C et al (2017) Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol 35(15):1641\u20131649. https:\/\/doi.org\/10.1200\/JCO.2016.72.0722","journal-title":"J Clin Oncol"},{"issue":"1","key":"7677_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1586\/14737140.2016.1121111","volume":"16","author":"LC Mendez","year":"2016","unstructured":"Mendez LC et al (2016) The management of head and neck tumors with high technology radiation therapy. Expert Rev Anticancer Ther 16(1):99\u2013110. https:\/\/doi.org\/10.1586\/14737140.2016.1121111","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"7677_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.radonc.2013.11.010","volume":"110","author":"GN Marta","year":"2014","unstructured":"Marta GN et al (2014) Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. Radiother Oncol 110(1):9\u201315. https:\/\/doi.org\/10.1016\/j.radonc.2013.11.010","journal-title":"Radiother Oncol"},{"key":"7677_CR29","doi-asserted-by":"publisher","first-page":"103090","DOI":"10.1016\/j.critrevonc.2020.103090","volume":"156","author":"GN Marta","year":"2020","unstructured":"Marta GN et al (2020) The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: a critical review. Crit Rev Oncol Hematol 156:103090. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103090","journal-title":"Crit Rev Oncol Hematol"},{"key":"7677_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.breast.2022.01.018","volume":"62","author":"GN Marta","year":"2022","unstructured":"Marta GN et al (2022) Moderately hypofractionated post-operative radiation therapy for breast cancer: systematic review and meta-analysis of randomized clinical trials. Breast 62:84\u201392. https:\/\/doi.org\/10.1016\/j.breast.2022.01.018","journal-title":"Breast"},{"issue":"1","key":"7677_CR31","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","volume":"23","author":"I Meattini","year":"2022","unstructured":"Meattini I et al (2022) European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol 23(1):e21\u2013e31. https:\/\/doi.org\/10.1016\/S1470-2045(21)00539-8","journal-title":"Lancet Oncol"},{"issue":"7","key":"7677_CR32","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1016\/S1470-2045(21)00260-6","volume":"22","author":"GN Marta","year":"2021","unstructured":"Marta GN, Meattini I (2021) Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial. Lancet Oncol 22(7):e297. https:\/\/doi.org\/10.1016\/S1470-2045(21)00260-6","journal-title":"Lancet Oncol"},{"issue":"1","key":"7677_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/tbj.13164","volume":"25","author":"FA Miranda","year":"2019","unstructured":"Miranda FA et al (2019) Accelerated partial breast irradiation: current status with a focus on clinical practice. Breast J 25(1):124\u2013128. https:\/\/doi.org\/10.1111\/tbj.13164","journal-title":"Breast J"},{"key":"7677_CR34","doi-asserted-by":"publisher","unstructured":"Martelletti LBSJ, Aguiar BRL, Vieira LAC, Men\u00eases AG, Bontempo PSM, Ferreira EB, Reis PEDD (2021) Incidence of acute radiodermatitis in women with breast cancer undergoing hypofractionated radiotherapy. Rev Bras Enferm 75(1):e20210118. https:\/\/doi.org\/10.1590\/0034-7167-2021-0118\u00a0(English, Portuguese)","DOI":"10.1590\/0034-7167-2021-0118"},{"key":"7677_CR35","doi-asserted-by":"publisher","unstructured":"Wolverton SE (2021) 1 - basic principles of pharmacology.\u00a0In: Wolverton SE (ed) Comprehensive dermatologic drug therapy, 4th edn. Elsevier, pp 1\u201311. https:\/\/doi.org\/10.1016\/B978-0-323-61211-1.00001-2","DOI":"10.1016\/B978-0-323-61211-1.00001-2"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07677-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07677-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07677-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T08:08:21Z","timestamp":1681546101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07677-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["7677"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07677-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"217"}}